Argatroban, A Selective, Potent Thrombin Inhibitor
- 1 September 1991
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 9 (3) , 247-263
- https://doi.org/10.1111/j.1527-3466.1991.tb00415.x
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Geometry of binding of the benzamidine‐ and arginine‐based inhibitors Nα‐(2‐naphthyl‐sulphonyl‐glycyl)‐dl‐p‐amidinophenylalanyl‐piperidine (NAPAP) and (2R,4R)‐4‐methyl‐1‐[Nα‐(3‐methyl‐1,2,3,4‐tetrahydro‐8‐quinolinesulphonyl)‐l‐arginyl]‐2‐piperidine carboxylic acid (MQPA) to human α‐thrombinEuropean Journal of Biochemistry, 1990
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Regulation of Thrombin Generation at Cell SurfacesSeminars in Thrombosis and Hemostasis, 1988
- Role of heparin after intravenous thrombolytic therapy for acute myocardial infarctionThe American Journal of Cardiology, 1987
- Responses of Aortic Smooth Muscle to Thrombin and Thrombin AnaloguesaAnnals of the New York Academy of Sciences, 1986
- The Regulation of Hemostasis: The Protein C SystemNew England Journal of Medicine, 1986
- Fibrinopeptide A: a marker of acute coronary thrombosis.Circulation, 1985
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathNew England Journal of Medicine, 1984
- Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portionBiochemical and Biophysical Research Communications, 1981
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976